Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
23
CATX Quote, Financials, Valuation and Earnings
Last price:
$2.87
Seasonality move
:
41.25%
Day range:
$2.80 - $2.96
52-week range:
$2.70 - $19.05
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
15.39x
P/B ratio:
0.59x
Volume:
2.9M
Avg. volume:
2.3M
1-year change:
-16.67%
Market cap:
$192.6M
Revenue:
--
EPS (TTM):
-$1.46
Earnings Data
Next earnings date for CATX
Mar 28
2025
Most recent earnings per share
-$0.21
Missed by $0.01
(Nov 12/2024)
Consensus Estimate
-$0.20
(Nov 12/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CATX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/28/2025 | Q4 | $257.8K | -- | -- | -$0.26 | -- |
| 11/12/2024 | Q3 | $237.9K | -- | -$0.21 | -$0.20 | -$0.01 |
| 08/12/2024 | Q2 | $135.6K | -- | -$0.18 | -- | -- |
| 05/15/2024 | Q1 | $68.8K | -- | -$0.20 | -- | -- |
| 03/28/2024 | Q4 | $2.1M | -- | -$0.87 | -- | -- |
| 11/14/2023 | Q3 | $2.2M | -- | -$0.37 | -- | -- |
| 08/11/2023 | Q2 | $2.6M | -- | -$0.40 | -- | -- |
| 05/16/2023 | Q1 | -- | -- | -- | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$0.02 | -- | -- |
| 11/10/2022 | Q3 | -- | $1.7M | -$0.30 | -- | -- |
| 06/30/2022 | Q2 | -- | $2.5M | -$0.10 | -- | -- |
| 03/31/2022 | Q1 | -- | $2.9M | -$0.10 | -- | -- |
| 12/31/2021 | Q4 | -- | $2.8M | -$0.10 | -- | -- |
| 09/30/2021 | Q3 | -- | $2.6M | -$0.20 | -- | -- |
| 06/30/2021 | Q2 | -- | $2.7M | -$0.10 | -- | -- |
| 03/31/2021 | Q1 | -- | $2.6M | -$0.10 | -- | -- |
| 12/31/2020 | Q4 | -- | $2.4M | -$0.10 | -- | -- |
| 09/30/2020 | Q3 | -- | $2.4M | -$0.10 | -- | -- |
| 06/30/2020 | Q2 | -- | $2.3M | -$0.20 | -- | -- |
| 03/31/2020 | Q1 | -- | $2.9M | -$0.10 | -- | -- |
| 12/31/2019 | Q4 | -- | $2.2M | -$0.10 | -- | -- |
| 09/30/2019 | Q3 | -- | $2.3M | -$0.10 | -- | -- |
| 06/30/2019 | Q2 | -- | $1.9M | -$0.20 | -- | -- |
| 03/31/2019 | Q1 | -- | $1.9M | -$0.20 | -- | -- |
| 12/31/2018 | Q4 | -- | $1.9M | -$0.20 | -- | -- |
| 09/30/2018 | Q3 | -- | $1.6M | -$0.20 | -- | -- |
| 06/30/2018 | Q2 | -- | $1.6M | -$0.43 | -- | -- |
| 03/31/2018 | Q1 | -- | $1.6M | -$0.24 | -- | -- |
| 12/31/2017 | Q4 | -- | $1.5M | -$0.30 | -- | -- |
| 09/30/2017 | Q3 | -- | $1.2M | -$0.30 | -- | -- |
| 06/30/2017 | Q2 | -- | $1.4M | -$0.30 | -- | -- |
| 03/31/2017 | Q1 | -- | $1.3M | -$0.25 | -- | -- |
| 12/31/2016 | Q4 | -- | $1M | -$0.30 | -- | -- |
| 09/30/2016 | Q3 | -- | $1.1M | -$0.30 | -- | -- |
| 06/30/2016 | Q2 | -- | $1.1M | -$0.30 | -- | -- |
| 03/31/2016 | Q1 | -- | $1.2M | -$0.20 | -- | -- |
| 12/31/2015 | Q4 | -- | $1.2M | -$0.20 | -- | -- |
| 09/30/2015 | Q3 | -- | $1.3M | -$0.20 | -- | -- |
| 06/30/2015 | Q2 | -- | $1.3M | -$0.20 | -- | -- |
| 03/31/2015 | Q1 | -- | $1.2M | -$0.20 | -- | -- |
| 12/31/2014 | Q4 | -- | $1.1M | -$0.20 | -- | -- |
Perspective Therapeutics Earnings Questions
-
How Much did Perspective Therapeutics Generate in Revenue Last Quarter?
Perspective Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Perspective Therapeutics Beat Earnings Last Quarter?
Perspective Therapeutics announced earnings per share of -$0.21 which represents a miss of analyst forecast a -$0.20 per share.
-
Is Perspective Therapeutics Profitable?
Perspective Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Perspective Therapeutics EPS Next Year?
Perspective Therapeutics's earnings are forecast to decrease from -$1.70 per share to -- per share next year representing a decrease of -50.73%.
-
When is Perspective Therapeutics's Earnings Date?
Perspective Therapeutics's next earnings date is March 28, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
